Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISIS 113715 Monotherapy in Type 2 Diabetes
NCT00330200Phase 2Terminated
- Sponsor
- Ionis Pharmaceuticals
- Start
- Nov 2005
- Primary completion
- Mar 2007
- Modality
- Modified DNA Oligonucleotides, Single-strand DNA, Antisense Oligonucleotides (ASOs)
- Countries
- 1
01
Overview
A Phase 2 trial of IONIS-PTP-1BRx in type 2 diabetes mellitus (T2DM), sponsored by Ionis Pharmaceuticals. Started Nov 2005; status: terminated.
02
Drugs
IONIS-PTP-1BRx
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00330200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00330200.